diazoxide has been researched along with Acute Confusional Senile Dementia in 4 studies
Diazoxide: A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group.
diazoxide : A benzothiadiazine that is the S,S-dioxide of 2H-1,2,4-benzothiadiazine which is substituted at position 3 by a methyl group and at position 7 by chlorine. A peripheral vasodilator, it increases the concentration of glucose in the plasma and inhibits the secretion of insulin by the beta- cells of the pancreas. It is used orally in the management of intractable hypoglycaemia and intravenously in the management of hypertensive emergencies.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, Q | 2 |
| Gao, N | 1 |
| Che, F | 1 |
| Xu, G | 1 |
| Han, H | 1 |
| Su, Q | 1 |
| Ma, G | 2 |
| Liu, D | 2 |
| Ahmet, I | 1 |
| Griess, B | 1 |
| Tweedie, D | 1 |
| Greig, NH | 2 |
| Mattson, MP | 2 |
| Gao, J | 1 |
| Jiang, L | 1 |
| Wang, R | 1 |
| Zhang, Y | 1 |
| Liu, K | 1 |
| Pitta, M | 1 |
| Lee, JH | 1 |
| Ray, B | 1 |
| Lahiri, DK | 1 |
| Furukawa, K | 1 |
| Mughal, M | 1 |
| Jiang, H | 1 |
| Villarreal, J | 1 |
| Cutler, RG | 1 |
4 other studies available for diazoxide and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Diphenyleneiodonium chloride synergizes with diazoxide to enhance protection against amyloid β induced neurotoxicity.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Survival; Diazoxide; Drug Synergism; Embryo, | 2019 |
Age-related impairment of cerebral blood flow response to K
Topics: Age Factors; Alzheimer Disease; Animals; Brain; Cerebrovascular Circulation; Diazoxide; KATP Channel | 2021 |
Diazoxide reverses the enhanced expression of KATP subunits in cholinergic neurons caused by exposure to Aβ₁₋₄₂.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cholinergic Agents; Diazoxide; KATP Channels; Neu | 2009 |
The KATP channel activator diazoxide ameliorates amyloid-β and tau pathologies and improves memory in the 3xTgAD mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Analysis of Variance; Anim | 2010 |